Guidelines

New guidelines update VTE treatment recommendations

Publish date: January 8, 2016

 

FROM CHEST

References

msullivan@frontlinemedcom.com

Pages

Recommended Reading

In PCI, switching clopidogrel nonresponders to prasugrel halved 2-year cardiac mortality
MDedge Emergency Medicine
Dicloxacillin may cut INR levels in warfarin users
MDedge Emergency Medicine
Home VTE treatment with rivaroxaban safe and effective
MDedge Emergency Medicine
NICE recommends rivaroxaban for acute coronary syndrome
MDedge Emergency Medicine
HIT risk rises with obesity
MDedge Emergency Medicine
For subacute STEMI, thrombectomy adds no benefit to PCI
MDedge Emergency Medicine
Idarucizumab approved as first agent to reverse a novel oral anticoagulant
MDedge Emergency Medicine
CHEST: Catheter-directed thrombolysis shows pulmonary embolism efficacy
MDedge Emergency Medicine
Andexanet reverses anticoagulant effects of factor Xa inhibitors
MDedge Emergency Medicine
Study characterizes intracerebral hemorrhage with new oral anticoagulants
MDedge Emergency Medicine